From Biology to Clinical Practice: Iron Chelation Therapy With Deferasirox

Iron chelation therapy (ICT) has become a mainstay in heavily transfused hematological patients, with the aim to reduce iron overload (IOL) and prevent organ damage. This therapeutic approach is already widely used in thalassemic patients and in low-risk Myelodysplastic Syndrome (MDS) patients. More...

Descripción completa

Detalles Bibliográficos
Autores principales: Palumbo, Giuseppe A., Galimberti, Sara, Barcellini, Wilma, Cilloni, Daniela, Di Renzo, Nicola, Elli, Elena Maria, Finelli, Carlo, Maurillo, Luca, Ricco, Alessandra, Musto, Pellegrino, Russo, Rodolfo, Latagliata, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527180/
https://www.ncbi.nlm.nih.gov/pubmed/34692534
http://dx.doi.org/10.3389/fonc.2021.752192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527180/
https://www.ncbi.nlm.nih.gov/pubmed/34692534
http://dx.doi.org/10.3389/fonc.2021.752192

Ejemplares similares